These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1305004)

  • 1. [Advances in the research on the pathogenic role of Campylobacter jejuni in Guillain-Barre syndrome].
    Tang J; Yuan JM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Dec; 25(6):375-7. PubMed ID: 1305004
    [No Abstract]   [Full Text] [Related]  

  • 2. Guillain-Barre syndrome and Campylobacter jejuni infection. A study on the etiological characteristics of Guillain-Barre syndrome in China.
    Yuan JM; Tang J; Chen QT; Xiao L; Hao HJ; Jia ZD; Huang QH; Liu XZ
    Chin Med J (Engl); 1993 Nov; 106(11):845-7. PubMed ID: 8143497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
    Tang J; Yuan J; Hao H
    Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Campylobacter jejuni infection and Guillain-Barre syndrome.
    Aguago JM; Ramos JT; Lumbreras C
    N Engl J Med; 1996 Mar; 334(12):802. PubMed ID: 8592566
    [No Abstract]   [Full Text] [Related]  

  • 5. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders.
    Enders U; Karch H; Toyka KV; Michels M; Zielasek J; Pette M; Heesemann J; Hartung HP
    Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Campylobacter jejuni and Guillain-Barré syndrome.
    Rees JH; Hughes RA
    Ann Neurol; 1994 Feb; 35(2):248-9. PubMed ID: 8109911
    [No Abstract]   [Full Text] [Related]  

  • 7. Campylobacter infections, Guillain-Barré syndrome, and parenteral gangliosides.
    Callegaro L; Jack DB; Samson JC
    Lancet; 1991 Mar; 337(8744):789. PubMed ID: 1672406
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-ganglioside antibodies in patients with Guillain-Barré syndrome and Campylobacter jejuni infection.
    Rees JH; Gregson NA; Hughes RA
    J Infect Dis; 1995 Aug; 172(2):605-6. PubMed ID: 7622918
    [No Abstract]   [Full Text] [Related]  

  • 9. [Campylobacter jejuni colitis and Guillain-Barre syndrome].
    Fujimoto S
    Fukuoka Igaku Zasshi; 1998 May; 89(5):127-32. PubMed ID: 9642872
    [No Abstract]   [Full Text] [Related]  

  • 10. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues.
    Kuroki S; Saida T; Nukina M; Haruta T; Yoshioka M; Kobayashi Y; Nakanishi H
    Ann Neurol; 1993 Mar; 33(3):243-7. PubMed ID: 8498807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Campylobacter jejuni bacteremia and Guillain-Barré syndrome in a patient with GVHD after allogeneic BMT.
    Hagensee ME; Benyunes M; Miller JA; Spach DH
    Bone Marrow Transplant; 1994 Mar; 13(3):349-51. PubMed ID: 8199580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The axon in Guillain-Barré syndrome: immune target or innocent bystander?
    Powell HC; Myers RR
    Ann Neurol; 1996 Jan; 39(1):4-5. PubMed ID: 8572665
    [No Abstract]   [Full Text] [Related]  

  • 13. Serologic evidence of Campylobacter jejuni/coli enteritis in patients with Guillain-Barré syndrome.
    Gruenewald R; Ropper AH; Lior H; Chan J; Lee R; Molinaro VS
    Arch Neurol; 1991 Oct; 48(10):1080-2. PubMed ID: 1929902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Workshop summary and recommendations regarding the development of Guillain-Barré syndrome following Campylobacter infection.
    Lang DR; Allos BM; Blaser MJ
    J Infect Dis; 1997 Dec; 176 Suppl 2():S198-200. PubMed ID: 9396711
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
    Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
    Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome.
    Mishu B; Ilyas AA; Koski CL; Vriesendorp F; Cook SD; Mithen FA; Blaser MJ
    Ann Intern Med; 1993 Jun; 118(12):947-53. PubMed ID: 8489109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
    Yuki N
    Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polyradiculoneuritis and Campylobacter jejuni: clinical and physiopathological aspects].
    Diagana M; Khalil M; Preux PM; Dumas M; Jauberteau MO
    Med Trop (Mars); 2003; 63(1):68-74. PubMed ID: 12891754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies.
    Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N
    Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Guillain-Barré syndrome at 75: the Campylobacter connection.
    Griffin JW; Ho TW
    Ann Neurol; 1993 Aug; 34(2):125-7. PubMed ID: 8338335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.